AWSHX
Price
$68.83
Change
+$0.27 (+0.39%)
Updated
Jun 2 closing price
Net Assets
214.46B
EICIX
Price
$18.49
Change
+$0.05 (+0.27%)
Updated
Jun 2 closing price
Net Assets
366.65M
Interact to see
Advertisement

AWSHX vs EICIX

Header iconAWSHX vs EICIX Comparison
Open Charts AWSHX vs EICIXBanner chart's image
AWSHX vs EICIX Comparison Chart in %
View a ticker or compare two or three
VS
AWSHX vs. EICIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSHX is a Hold and EICIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AWSHX has more cash in the bank: 214B vs. EICIX (367M). EICIX pays higher dividends than AWSHX: EICIX (2.19) vs AWSHX (1.19). AWSHX was incepted earlier than EICIX: AWSHX (74 years) vs EICIX (15 years). EICIX (0.98) is less costly to investors than AWSHX (0.55). AWSHX (29.00) and EICIX (29.00) have comparable annual turnover. AWSHX has a lower initial minimum investment than EICIX: AWSHX (250) vs EICIX (10000). AWSHX annual gain was more profitable for investors over the last year : 7.86 vs. EICIX (4.67). AWSHX return over 5 years is better than : 25.50 vs. EICIX (19.22).
AWSHXEICIXAWSHX / EICIX
Total Expense Ratio0.550.9657%
Annual Report Gross Expense Ratio0.550.9856%
Fund Existence74 years15 years-
Gain YTD5.4713.017181%
Front Load6%N/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets214B367M58,311%
Annual Yield % from dividends1.192.1954%
Returns for 1 year7.864.67168%
Returns for 3 years32.1532.4599%
Returns for 5 years25.5019.22133%
Returns for 10 years83.4365.50127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOVNP20.810.08
+0.36%
Hovnanian Enterprises
BLD407.07-5.12
-1.24%
TopBuild Corp
IMOS64.61-1.96
-2.94%
ChipMOS TECHNOLOGIES
FLNA1.44-0.05
-3.36%
Filana Therapeutics Inc
OVID2.40-0.16
-6.25%
Ovid Therapeutics